Pacer Advisors’s Generation Bio GBIO Stock Holding History

Pacer Advisors’s Portfolio GBIO Stock Details GBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-224	Closed	-$64K	–	1459
2021 Q1	$64K	Buy	224 +154	+220%	+$49.3K	﹤0.01%	1405
2020 Q4	$20K	Buy	+70	New	+$22.5K	﹤0.01%	1483

Other funds holding GBIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Pacer Advisors's GBIO Position: Q2 2021 in Review

Pacer Advisors sold out of Generation Bio (GBIO) in Q2 2021, closing a stake of 224 shares — an estimated $64K sold.

Pacer Advisors first reported a position in GBIO in Q4 2020 and held it in 2 quarters. The position peaked at $64K in Q1 2021. 97 funds tracked by Wall St. Rank hold GBIO as of Q2 2021.

Pacer Advisors reported no remaining Generation Bio position as of Q2 2021 after selling out during the quarter.
Pacer Advisors sold 224 Generation Bio shares in Q2 2021, an estimated $64K.
Pacer Advisors first reported a position in Generation Bio in Q4 2020 and held it in 2 quarters.
Pacer Advisors's Generation Bio position peaked at $64K in Q1 2021.
97 funds tracked by Wall St. Rank held Generation Bio as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.